Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Alzheimer’s Disease Biomarker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4698994
    • |
  • 21 May, 2026
    • |
  • Global
    • |
  • 118 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Alzheimer’s Disease Biomarker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Alzheimer’s Disease Biomarker market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alzheimer’s Disease Biomarker market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alzheimer’s Disease Biomarker market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alzheimer’s Disease Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Alzheimer’s Disease Biomarker market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alzheimer’s Disease Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alzheimer’s Disease Biomarker market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Enzo Life Sciences, Thermo Fisher Scientific, AnaSpec, Merck KGaA, Cell Signaling Technology, Fujirebio, Imagilys, NanoSomiX, QIAGEN, 23andMe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Alzheimer’s Disease Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Molecular Diagnostics
Immunoassays
Market segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Major players covered
Enzo Life Sciences
Thermo Fisher Scientific
AnaSpec
Merck KGaA
Cell Signaling Technology
Fujirebio
Imagilys
NanoSomiX
QIAGEN
23andMe
Quanterix
C₂N Diagnostics
Quest Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer’s Disease Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alzheimer’s Disease Biomarker, with price, sales quantity, revenue, and global market share of Alzheimer’s Disease Biomarker from 2021 to 2026.
Chapter 3, the Alzheimer’s Disease Biomarker competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer’s Disease Biomarker breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Alzheimer’s Disease Biomarker market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alzheimer’s Disease Biomarker.
Chapter 14 and 15, to describe Alzheimer’s Disease Biomarker sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Alzheimer’s Disease Biomarker Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Molecular Diagnostics
    • 1.3.3 Immunoassays
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Alzheimer’s Disease Biomarker Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals and Clinics
    • 1.4.3 Diagnostic Laboratories
    • 1.4.4 Others
  • 1.5 Global Alzheimer’s Disease Biomarker Market Size & Forecast
    • 1.5.1 Global Alzheimer’s Disease Biomarker Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Alzheimer’s Disease Biomarker Sales Quantity (2021-2032)
    • 1.5.3 Global Alzheimer’s Disease Biomarker Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Enzo Life Sciences
    • 2.1.1 Enzo Life Sciences Details
    • 2.1.2 Enzo Life Sciences Major Business
    • 2.1.3 Enzo Life Sciences Alzheimer’s Disease Biomarker Product and Services
    • 2.1.4 Enzo Life Sciences Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Enzo Life Sciences Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Alzheimer’s Disease Biomarker Product and Services
    • 2.2.4 Thermo Fisher Scientific Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 AnaSpec
    • 2.3.1 AnaSpec Details
    • 2.3.2 AnaSpec Major Business
    • 2.3.3 AnaSpec Alzheimer’s Disease Biomarker Product and Services
    • 2.3.4 AnaSpec Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 AnaSpec Recent Developments/Updates
  • 2.4 Merck KGaA
    • 2.4.1 Merck KGaA Details
    • 2.4.2 Merck KGaA Major Business
    • 2.4.3 Merck KGaA Alzheimer’s Disease Biomarker Product and Services
    • 2.4.4 Merck KGaA Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Merck KGaA Recent Developments/Updates
  • 2.5 Cell Signaling Technology
    • 2.5.1 Cell Signaling Technology Details
    • 2.5.2 Cell Signaling Technology Major Business
    • 2.5.3 Cell Signaling Technology Alzheimer’s Disease Biomarker Product and Services
    • 2.5.4 Cell Signaling Technology Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Cell Signaling Technology Recent Developments/Updates
  • 2.6 Fujirebio
    • 2.6.1 Fujirebio Details
    • 2.6.2 Fujirebio Major Business
    • 2.6.3 Fujirebio Alzheimer’s Disease Biomarker Product and Services
    • 2.6.4 Fujirebio Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Fujirebio Recent Developments/Updates
  • 2.7 Imagilys
    • 2.7.1 Imagilys Details
    • 2.7.2 Imagilys Major Business
    • 2.7.3 Imagilys Alzheimer’s Disease Biomarker Product and Services
    • 2.7.4 Imagilys Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Imagilys Recent Developments/Updates
  • 2.8 NanoSomiX
    • 2.8.1 NanoSomiX Details
    • 2.8.2 NanoSomiX Major Business
    • 2.8.3 NanoSomiX Alzheimer’s Disease Biomarker Product and Services
    • 2.8.4 NanoSomiX Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 NanoSomiX Recent Developments/Updates
  • 2.9 QIAGEN
    • 2.9.1 QIAGEN Details
    • 2.9.2 QIAGEN Major Business
    • 2.9.3 QIAGEN Alzheimer’s Disease Biomarker Product and Services
    • 2.9.4 QIAGEN Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 QIAGEN Recent Developments/Updates
  • 2.10 23andMe
    • 2.10.1 23andMe Details
    • 2.10.2 23andMe Major Business
    • 2.10.3 23andMe Alzheimer’s Disease Biomarker Product and Services
    • 2.10.4 23andMe Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 23andMe Recent Developments/Updates
  • 2.11 Quanterix
    • 2.11.1 Quanterix Details
    • 2.11.2 Quanterix Major Business
    • 2.11.3 Quanterix Alzheimer’s Disease Biomarker Product and Services
    • 2.11.4 Quanterix Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Quanterix Recent Developments/Updates
  • 2.12 C₂N Diagnostics
    • 2.12.1 C₂N Diagnostics Details
    • 2.12.2 C₂N Diagnostics Major Business
    • 2.12.3 C₂N Diagnostics Alzheimer’s Disease Biomarker Product and Services
    • 2.12.4 C₂N Diagnostics Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 C₂N Diagnostics Recent Developments/Updates
  • 2.13 Quest Diagnostics
    • 2.13.1 Quest Diagnostics Details
    • 2.13.2 Quest Diagnostics Major Business
    • 2.13.3 Quest Diagnostics Alzheimer’s Disease Biomarker Product and Services
    • 2.13.4 Quest Diagnostics Alzheimer’s Disease Biomarker Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Quest Diagnostics Recent Developments/Updates

3 Competitive Environment: Alzheimer’s Disease Biomarker by Manufacturer

  • 3.1 Global Alzheimer’s Disease Biomarker Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Alzheimer’s Disease Biomarker Revenue by Manufacturer (2021-2026)
  • 3.3 Global Alzheimer’s Disease Biomarker Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Alzheimer’s Disease Biomarker by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Alzheimer’s Disease Biomarker Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Alzheimer’s Disease Biomarker Manufacturer Market Share in 2025
  • 3.5 Alzheimer’s Disease Biomarker Market: Overall Company Footprint Analysis
    • 3.5.1 Alzheimer’s Disease Biomarker Market: Region Footprint
    • 3.5.2 Alzheimer’s Disease Biomarker Market: Company Product Type Footprint
    • 3.5.3 Alzheimer’s Disease Biomarker Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Alzheimer’s Disease Biomarker Market Size by Region
    • 4.1.1 Global Alzheimer’s Disease Biomarker Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Alzheimer’s Disease Biomarker Consumption Value by Region (2021-2032)
    • 4.1.3 Global Alzheimer’s Disease Biomarker Average Price by Region (2021-2032)
  • 4.2 North America Alzheimer’s Disease Biomarker Consumption Value (2021-2032)
  • 4.3 Europe Alzheimer’s Disease Biomarker Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Alzheimer’s Disease Biomarker Consumption Value (2021-2032)
  • 4.5 South America Alzheimer’s Disease Biomarker Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Alzheimer’s Disease Biomarker Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 5.2 Global Alzheimer’s Disease Biomarker Consumption Value by Type (2021-2032)
  • 5.3 Global Alzheimer’s Disease Biomarker Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 6.2 Global Alzheimer’s Disease Biomarker Consumption Value by Application (2021-2032)
  • 6.3 Global Alzheimer’s Disease Biomarker Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 7.2 North America Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 7.3 North America Alzheimer’s Disease Biomarker Market Size by Country
    • 7.3.1 North America Alzheimer’s Disease Biomarker Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Alzheimer’s Disease Biomarker Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 8.2 Europe Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 8.3 Europe Alzheimer’s Disease Biomarker Market Size by Country
    • 8.3.1 Europe Alzheimer’s Disease Biomarker Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Alzheimer’s Disease Biomarker Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Alzheimer’s Disease Biomarker Market Size by Region
    • 9.3.1 Asia-Pacific Alzheimer’s Disease Biomarker Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Alzheimer’s Disease Biomarker Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 10.2 South America Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 10.3 South America Alzheimer’s Disease Biomarker Market Size by Country
    • 10.3.1 South America Alzheimer’s Disease Biomarker Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Alzheimer’s Disease Biomarker Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Alzheimer’s Disease Biomarker Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Alzheimer’s Disease Biomarker Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Alzheimer’s Disease Biomarker Market Size by Country
    • 11.3.1 Middle East & Africa Alzheimer’s Disease Biomarker Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Alzheimer’s Disease Biomarker Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Alzheimer’s Disease Biomarker Market Drivers
  • 12.2 Alzheimer’s Disease Biomarker Market Restraints
  • 12.3 Alzheimer’s Disease Biomarker Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Alzheimer’s Disease Biomarker and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Alzheimer’s Disease Biomarker
  • 13.3 Alzheimer’s Disease Biomarker Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Alzheimer’s Disease Biomarker Typical Distributors
  • 14.3 Alzheimer’s Disease Biomarker Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Alzheimer’s Disease Biomarker. Industry analysis & Market Report on Alzheimer’s Disease Biomarker is a syndicated market report, published as Global Alzheimer’s Disease Biomarker Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Alzheimer’s Disease Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo